Transforming growth factor-β is a potent inhibitor of extracellular matrix degradation by cultured human mesangial cells

Journal of the American Society of Nephrology

Volumn 10, Issue 4, 1999, Pages 790-795

  Baricos, William H ^a   Cortez, Shirley L ^a   Deboisblanc, Michael ^a   Shi, Xin ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; PLASMIN; PLASMINOGEN ACTIVATOR; PLATELET DERIVED GROWTH FACTOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; EXTRACELLULAR MATRIX; GLOMERULOSCLEROSIS; HUMAN; HUMAN CELL; MESANGIUM CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS;

EID: 0032983588     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/asn.v104790     Document Type: Article

References (39)

1. Klahr S, Schreiner G, Ichikawa I: The progression of renal disease. N Engl J Med 318: 1657-1666, 1988
2. Peten EP, Striker LJ: Progression of glomerular diseases. J Intern Med 236: 241-249, 1994
3. Bruijn JA, Roos A, de Geus B, de Heer E: Transforming growth factor-β and the glomerular extracellular matrix in renal pathology. J Lab Clin Med 123: 34-47, 1994
4. Sharma K, Ziyadeh FN: The emerging role of transforming growth factor-β in kidney diseases. Am J Physiol 266: F829-F842, 1994
5. Border WA, Noble NA: Transforming growth factor β in tissue fibrosis. N Engl J Med 331: 1286-1292, 1994
6. Okuda S, Nakamura T, Yamamoto T, Ruoslahti E, Border WA: Elevated expression of transforming growth factor β and proteoglycan production in experimental glomerulonephritis. J Clin Invest 86: 453-462, 1990
7. Coimbra T, Wiggins R, Noh JW, Merritt S, Phan SH: Transforming growth factor β production in antiglomerular basement membrane disease in the rabbit. Am J Pathol 138: 223-234, 1991
8. Lianos E, Liu J, Guglielmi K: Quantification of changes in transforming growth factor-β1 gene expression in experimental crescentic glomerulonephritis. Proc Soc Exp Biol Med 214: 180-186, 1996
9. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA: Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 90: 1814-1818, 1993
10. Iwano M, Kubo A, Nishino T, Sato H, Nishioka H, Akai Y, Kurioka H, Fujii Y, Kanauchi M, Shiki H, Dohi K: Quantification of glomerular TGFβ-1 mRNA in patients with diabetes mellitus. Kidney Int 49: 1120-1126, 1996
11. Iwano M, Akai Y, Fujii Y, Dohi Y, Matsumara N, Dohi K: Intraglomerular expression of transforming growth factor-beta 1 (TGF-β1) mRNA in patients with glomerulonephritis: Quantitative analysis by competitive polymerase chain reaction. Clin Exp Immunol 91: 309-314, 1994
12. Yamamoto T, Noble NA, Miller DE, Border WA: Sustained expression of TGF-β1 underlies development of progressive kidney fibrosis. Kidney Int 45: 916-927, 1994
13. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature (Lond) 346: 371-374, 1990
14. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, Ruoslahti E: Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature (Lond) 360: 361-364, 1992
15. Isaka Y, Fujiwara Y, Ueda N, Kaneda Y, Kamada T, Imai E: Glomerulosclerosis induced by in vivo transfection of transforming growth factor-β or platelet-derived growth factor gene into the rat kidney. J Clin Invest 92: 2597-2601, 1993
16. Akagi Y, Isaka Y, Arai M, Kaneko T, Takenaka M, Moriyama T, Kaneda Y, Ando A, Orita Y, Kamada T, Ueda N, Imai E: Inhibition of TGF-β1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int 50: 148-155, 1996
17. Kanai H, Mitushashi N, Ono R, Yano M, Naruse N: Increased excretion of urinary transforming growth factor beta in patients with focal glomerular sclerosis. Nephron 66: 391-395, 1994
18. Kopp JB, Factor VM, Mozes M, Nagy P, Sanderson N, Bottinger EP, Klotman PE, Thorgeirsson SS: Transgenic mice with increased plasma levels of TGF-β1 develop progressive renal disease. Lab Invest 74: 991-1003, 1996
19. Clouthier DE, Comerford SA, Hammer RE: Hepatic fibrosis, glomerulosclerosis, and lipodystrophy-like syndrome in PEPCK-TGFβ transgenic mice. J Clin Invest 100: 2697-2713, 1997
20. Border WA, Okuda S, Languino R, Ruoslahti E: Transforming growth factor β regulates production of proteoglycans by mesangial cells. Kidney Int 37: 689-695, 1990
21. Nakamura T, Okuda S, Ruoslahti E, Border WA: Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-β1. Kidney Int 41: 1213-1221, 1992
22. MacKay K, Stricker L, Stauffer JW, Doi T, Agoda LY, Stricker GE: Transforming growth factor β: Murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest 83: 160-167, 1989
23. Ziyadeh FN, Sharma K, Ericksen M, Wolf G: Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by activation of transforming growth factor-β. J Clin Invest 93: 536-542, 1994
24. Sharma K, Jin Y, Ziyadeh FN: Neutralization of TGF-β by anti-TGFβ antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 45: 522-530, 1996
25. Baricos WH, Cortez SL, El-Dahr SS, Schnaper HW: ECM degradation by cultured human mesangial cells is mediated by a plasminogen activator/plasmin/MMP-2 cascade. Kidney Int 47: 1039-1047, 1995
26. Wong AP, Cortez SL, Baricos WH: Role of plasmin and gelatinase in extracellular matrix degradation by cultured rat mesangial cells. Am J Physiol 263: F1112-F1118, 1992
27. Feng L, Tang WW, Loskutoff DJ, Wilson CB: Dysfunction of glomerular fibrinolysis in experimental antiglomerular basement membrane antibody glomerulonephritis. J Am Soc Nephrol 3: 1753-1764, 1993
28. Malliaros J, Holdsworth SR, Wojta J, Erlich J, Tipping PG: Glomerular fibrinolytic activity in anti-GBM glomerulonephritis in rabbits. Kidney Int 44: 557-564, 1993
29. Tomooka S, Border WA, Marshall BC, Noble NA: Glomerular matrix accumulation is linked to inhibition of the plasmin protease system. Kidney Int 42: 1462-1469, 1992
30. Loskutoff DJ, Sawdey M, Keeton M, Schneiderman J: Regulation of PAI-1 gene expression in vivo. Thromb Haemostasis 70: 135-137, 1993
31. Kitching AR, Holdsworth SR, Ploplis VA, Plow EF, Collen D, Carmeliet P, Tipping PG: Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis. J Exp Med 185: 963-968, 1997
32. Kanalas JJ, Hopfer U: Effect of TGF-β1 and TNF-α on the plasminogen system of rat proximal tubular epithelial cells. J Am Soc Nephrol 8: 184-192, 1997
33. Shultz PJ, Knauss TC, Men P, Abboud HE: Mitogenic signals for thrombin in mesangial cells: Regulation of phospholipase C and PDGF genes. Am J Physiol 257: F366-F374, 1989
34. Zucker S, Conner C, DiMassmo BI, Ende H, Drews M, Seiki M, Bahou WF: Thrombin induces the activation of progelatinase A in vascular endothelial cells. J Biol Chem 270: 23730-23738, 1995
35. Abboud HE: Growth factors in glomerulonephritis. Kidney Int 43: 252-267, 1993
36. Martin J, Davies M, Thomas G, Lovett DH: Human mesangial cells secrete a GBM-degrading neutral proteinase and a specific inhibitor. Kidney Int 36: 790-801, 1989
37. Glass WF, Kreisberg JI, Troyer DA: Two-chain urokinase, receptor, and type 1 inhibitor in cultured human mesangial cells. Am J Physiol 264: F532-F539, 1992
38. Wilson HM, Haites NE, Reid FJ, Booth NA: Interleukin-1-beta up-regulates the plasminogen activator/plasmin system in human mesangial cells. Kidney Int 49: 1097-1104, 1996
39. Okumura Y, Sato H, Seiki M, Kido H: Proteolytic activation of the precursor of membrane type 1 matrix metalloproteinase by human plasmin: A possible cell surface activator. FEBS Lett 402: 181-184, 1997